Bibliographie (2362)
Randomized trial: Convalescent Plasma does not improve clinical status or overall mortality in severe Covid-19 pneumonia
mercredi, 25 novembre 2020 11:10 Écrit par Zouhair SouissiA Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia – New England Journal of Medicine Commentary: New trial of convalescent plasma for covid-19 falls flat, another setback for hyped treatment – Brief19 Commentary on Twitter A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia @NEJM A well conducted RCT shows no significant […]
The post Randomized trial: Convalescent Plasma does not improve clinical status or overall mortality in severe Covid-19 pneumonia appeared first on Links Medicus.
Data show hospitalized Covid-19 patients are surviving at higher rates, but surge in cases could roll back gains
mardi, 24 novembre 2020 11:32 Écrit par Zouhair SouissiData show hospitalized Covid-19 patients are surviving at higher rates, but surge in cases could roll back gains – STAT
The post Data show hospitalized Covid-19 patients are surviving at higher rates, but surge in cases could roll back gains appeared first on Links Medicus.
Why does the AstraZeneca-Oxford COVID-19 vaccine’s efficacy vary so much? Here’s what we know
mardi, 24 novembre 2020 11:32 Écrit par Zouhair SouissiWhy Does the AstraZeneca COVID-19 Vaccine’s Efficacy Vary So Much? Here’s What We Know – TIME Related: Why Oxford’s positive COVID vaccine results are puzzling scientists – Nature
The post Why does the AstraZeneca-Oxford COVID-19 vaccine’s efficacy vary so much? Here’s what we know appeared first on Links Medicus.
Emergency COVID-vaccine approvals pose a dilemma for scientists. It could complicate efforts to study long-term outcomes, such as safety, how long protection lasts and whether the jab prevents infection or just the disease
mardi, 24 novembre 2020 11:32 Écrit par Zouhair SouissiWhy emergency COVID-vaccine approvals pose a dilemma for scientists – Nature
The post Emergency COVID-vaccine approvals pose a dilemma for scientists. It could complicate efforts to study long-term outcomes, such as safety, how long protection lasts and whether the jab prevents infection or just the disease appeared first on Links Medicus.
Why the AstraZeneca-Oxford Covid-19 vaccine is different. It does not require extremely cold temperatures for storage, and the price will be “a fraction” of the expense of the other vaccine candidates
mardi, 24 novembre 2020 11:32 Écrit par Zouhair SouissiWhy the AstraZeneca-Oxford Covid-19 vaccine is different – Vox
The post Why the AstraZeneca-Oxford Covid-19 vaccine is different. It does not require extremely cold temperatures for storage, and the price will be “a fraction” of the expense of the other vaccine candidates appeared first on Links Medicus.
Diagnosis, management, and pathophysiology of arterial and venous thrombosis in COVID-19
mardi, 24 novembre 2020 11:32 Écrit par Zouhair SouissiDiagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19 – JAMA Commentary on Twitter Arterial and venous thrombosis are common in #COVID19, especially in critically ill patients. Thromboprophylaxis should be considered for all hospitalized patients with COVID-19 in the absence of contraindications https://t.co/sjqL7MqGLX — JAMA (@JAMA_current) November 23, 2020
The post Diagnosis, management, and pathophysiology of arterial and venous thrombosis in COVID-19 appeared first on Links Medicus.
Meta-analysis: SARSCoV2 most contagious within the first 5 days of symptom onset
lundi, 23 novembre 2020 12:21 Écrit par Zouhair SouissiSARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis – The Lancet Microbe Commentaries: COVID-19 most contagious in first 5 days of illness, study finds – CIDRAP AND Infectiousness peaks early in COVID-19 patients, emphasising the need to rapidly isolate cases – The Lancet AND Covid-19 […]
The post Meta-analysis: SARSCoV2 most contagious within the first 5 days of symptom onset appeared first on Links Medicus.
Covid-19: Oxford University vaccine shows 70% protection
lundi, 23 novembre 2020 12:21 Écrit par Zouhair SouissiCovid-19: Oxford University vaccine shows 70% protection – BBC News release: Oxford University breakthrough on global COVID-19 vaccine Commentary on Twitter Today marks an important milestone in the fight against #COVID19. Interim data show the #OxfordVaccine is 70.4% effective, & tests on two dose regimens show that it could be 90%, moving us one […]
The post Covid-19: Oxford University vaccine shows 70% protection appeared first on Links Medicus.
Systematic review: Interventions for breathlessness in patients with advanced cancer
lundi, 23 novembre 2020 10:51 Écrit par Zouhair SouissiInterventions for Breathlessness in Patients With Advanced Cancer – Agency for Healthcare Research and Quality Full report: Interventions for breathlessness in patients with advanced cancer Evidence Summary: Interventions for breathlessness in patients with advanced cancer
The post Systematic review: Interventions for breathlessness in patients with advanced cancer appeared first on Links Medicus.
A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: Illness beyond acute infection and public health implications
lundi, 23 novembre 2020 10:51 Écrit par Zouhair SouissiA Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection: Illness Beyond Acute Infection and Public Health Implications – JAMA Commentary on Twitter The #COVID19 response focuses on acute illness, but accumulating evidence shows morbidity beyond acute infection, with at least 2 other periods of illness: a rare postacute hyperinflammatory […]
The post A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: Illness beyond acute infection and public health implications appeared first on Links Medicus.
